Zoetis Slashes 2026 EPS Outlook to $6.35-$6.50
Summary
Zoetis Inc. has significantly lowered its earnings per share (EPS) guidance for fiscal year 2026 to a range of $6.35 to $6.50. This revised outlook represents a material reduction in the company's financial expectations, following its strong 2025 results reported in February. The downward revision is a negative catalyst, likely to pressure the stock, especially given its current proximity to 52-week lows. Professional traders will need to reassess valuation models and monitor for further commentary on the underlying drivers of this reduced forecast.
At the time of this announcement, ZTS was trading at $103.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $46.8B. The 52-week trading range was $110.94 to $172.23. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.